Efficacy and Safety of the Absorb Bioresorbable Vascular Scaffold in Females and Males Results of an Individual Patient-Level Pooled Meta-Analysis of Randomized Controlled Trials

摘要

OBJECTIVES Because females are under-represented in coronary trials, this study sought to assess the relative safety and efficacy of Absorb bioresorbable vascular scaffold (BVS) (Abbott Vascular, Santa Clara, California) and the Xience everolimus-eluting stent in females compared with males.